Article By:
Hashtag Investing
Monday, March 15, 2021 6:45 AM EDT
While COVID-19 has taken center stage for the past year, there remains a huge need for advance testing, treatment options and cures for other diseases. That points toward personalized medicine and next-generation genomic sequencing (NGS) solutions.